<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Wang J</submitter><funding>Young Scientists</funding><funding>Strategic Priority Research Program of the Chinese Academy of Sciences</funding><funding>Western Light Innovative Research Team of Chinses Academy of Sciences</funding><funding>NIA NIH HHS</funding><funding>NIDA NIH HHS</funding><funding>NIMH NIH HHS</funding><funding>National Nature Science Foundation of China</funding><funding>NIH</funding><funding>Key Research Project</funding><pagination>2569-2585</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9612800</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>145(7)</volume><pubmed_abstract>Recent genome-wide association studies have reported multiple schizophrenia risk loci, yet the functional variants and their roles in schizophrenia remain to be characterized. Here we identify a functional single nucleotide polymorphism (rs2270363: G>A) at the schizophrenia risk locus 16p13.3. rs2270363 lies in the E-box element of the promoter of NMRAL1 and disrupts binding of the basic helix-loop-helix leucine zipper family proteins, including USF1, MAX and MXI1. We validated the regulatory effects of rs2270363 using reporter gene assays and electrophoretic mobility shift assay. Besides, expression quantitative trait loci analysis showed that the risk allele (A) of rs2270363 was significantly associated with elevated NMRAL1 expression in the human brain. Transcription factors knockdown a</pubmed_abstract><journal>Brain : a journal of neurology</journal><pubmed_title>Functional variant rs2270363 on 16p13.3 confers schizophrenia risk by regulating NMRAL1.</pubmed_title><pmcid>PMC9612800</pmcid><funding_grant_id>P50 AG005138</funding_grant_id><funding_grant_id>202001AV070006</funding_grant_id><funding_grant_id>P50 MH096891</funding_grant_id><funding_grant_id>202101AS070055</funding_grant_id><funding_grant_id>P50 MH066392</funding_grant_id><funding_grant_id>XDPB17</funding_grant_id><funding_grant_id>R01 MH080405</funding_grant_id><funding_grant_id>R01 MH097276</funding_grant_id><funding_grant_id>P01 AG002219</funding_grant_id><funding_grant_id>R01 MH075916</funding_grant_id><funding_grant_id>R37 MH057881</funding_grant_id><funding_grant_id>P50 MH084051</funding_grant_id><funding_grant_id>F31 AG051381</funding_grant_id><funding_grant_id>31970561</funding_grant_id><funding_grant_id>P50 MH084053</funding_grant_id><funding_grant_id>HHSN271201300031C</funding_grant_id><funding_grant_id>U2102205</funding_grant_id><funding_grant_id>R01 MH085542</funding_grant_id><funding_grant_id>U1904130</funding_grant_id><funding_grant_id>R01 MH093725</funding_grant_id><pubmed_authors>Liu J</pubmed_authors><pubmed_authors>Yang J</pubmed_authors><pubmed_authors>Li J</pubmed_authors><pubmed_authors>Huang D</pubmed_authors><pubmed_authors>Xiao X</pubmed_authors><pubmed_authors>Li K</pubmed_authors><pubmed_authors>Wang J</pubmed_authors><pubmed_authors>Li M</pubmed_authors><pubmed_authors>Li W</pubmed_authors><pubmed_authors>Li X</pubmed_authors><pubmed_authors>Liu Y</pubmed_authors><pubmed_authors>Li Y</pubmed_authors><pubmed_authors>Lv L</pubmed_authors><pubmed_authors>Yang Y</pubmed_authors><pubmed_authors>Li S</pubmed_authors><pubmed_authors>Luo XJ</pubmed_authors><pubmed_authors>Chen R</pubmed_authors></additional><is_claimable>false</is_claimable><name>Functional variant rs2270363 on 16p13.3 confers schizophrenia risk by regulating NMRAL1.</name><description>Recent genome-wide association studies have reported multiple schizophrenia risk loci, yet the functional variants and their roles in schizophrenia remain to be characterized. Here we identify a functional single nucleotide polymorphism (rs2270363: G>A) at the schizophrenia risk locus 16p13.3. rs2270363 lies in the E-box element of the promoter of NMRAL1 and disrupts binding of the basic helix-loop-helix leucine zipper family proteins, including USF1, MAX and MXI1. We validated the regulatory effects of rs2270363 using reporter gene assays and electrophoretic mobility shift assay. Besides, expression quantitative trait loci analysis showed that the risk allele (A) of rs2270363 was significantly associated with elevated NMRAL1 expression in the human brain. Transcription factors knockdown a</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Jul</publication><modification>2026-05-03T10:52:52.397Z</modification><creation>2024-11-13T05:17:32.511Z</creation></dates><accession>S-EPMC9612800</accession><cross_references><pubmed>35094059</pubmed><doi>10.1093/brain/awac020</doi></cross_references></HashMap>